In response to Viagra
 |  Post Reply

Shortages of influenza vaccine shots could enhance disappointing sales of the needle-free vaccine FluMist this winter, however some analysts say the drug’s long term outlook is still dogged by a excessive price and limits on who can use it. But the drug’s introduction was hampered by a number of components. The higher demand might assist the drug overcome its high cost - which has hampered its roll out this season. Allowing the life-saving naloxone nasal spray on Winnipeg Transit buses would assist handle the city's overdose crisis, according to at least one city councillor. The committee determined to refer the concept to the town's transit advisory committee. Through the assembly, transit director Greg Ewankiw laid out what areas city workers would have to look into if this were to be carried out. There's also the chance of an allergic reaction, Ewankiw says. Citing safety issues, the Food and Drug Administration did not approve FluMist for kids below 5 years and those above 50, the two teams at the best risk for the flu.

At pharmacies in 33 Giant Food grocery stores in Virginia, FluMist sales tripled last week over the earlier week, company spokesman Jamie Miller stated. The corporate earlier predicted it might make between $one hundred twenty million and $140 million on the drug, however dropped the forecast to between $fifty five million and $85 million. The company pumped $25 million into an ad marketing campaign touting the drug to shoppers and another $25 million pitching it to pharmacies. There may be plenty of the nasal spray vaccine obtainable - only 400,000 doses out of the roughly 4 million doses made by Gaithersburg-based mostly MedImmune and its associate, Wyeth, have been distributed to pharmacies and flu vaccine sites. It hoped FluMist can be a blockbuster drug, much like its childhood respiratory drug Synagis that had $668 million in sales last yr. FluMist was accredited for use in Canada in 2010. Currently, it is strongly recommended for most wholesome children and teens aged 2 to 17 yr. The federal Centers for Disease Control additionally mentioned final week that FluMist is an effective alternative to a shot.

FluMist sells for $59.95 at Giant, while a traditional flu shot is $20, he said. Last month, MedImmune downgraded its outlook for 2003 primarily based largely on sagging FluMist gross sales. MedImmune spokeswoman Jamie Lacey said it was too early to inform how the vaccine shortage would have an effect on FluMist sales. MedImmune and Wyeth now provide a $25 mail-in rebate for FluMist customers to attempt to cut the price. Abstract:In addition to topical supply, nasal sprays offer another drug administration route to the systemic circulation, due to this fact avoiding the need for painful, invasive supply techniques. And the drug, originally billed as a painless alternative for youngsters fearful of needles, hasn’t been accepted to be used by toddlers and seniors. Colorado, which has reported six flu deaths, really helpful last week that healthy folks between the ages of five and 49 use FluMist to save dwindling flu shot stocks for young kids and the elderly, who cannot use the nasal spray. Health officials reported Wednesday that the spray performed dismally for the third straight yr, whereas the traditional flu shot - the one which stings - labored moderately properly this winter.

But as a result of it's primarily used in youngsters, about a third of the flu vaccinations of youngsters had been executed with FluMist, health officials say. The product, AstraZeneca's FluMist, was as soon as thought to be the very best vaccine for protecting youngsters towards flu. FluMist, which contains a reside but weakened flu virus, is meant to be a painless various to the normal flu injection, which is made from a lifeless flu virus. Klein instructed having naloxone on buses instead approach, but rescinded that movement before council discussed it. Ontario is introducing a new nasal spray flu vaccine this 12 months as an alternative to an injection within the arm. On Wednesday, a federal advisory committee on immunization voted to retract its endorsement of the vaccine after preliminary CDC study results presented to the committee showed it provided no protection from the flu strain that made most people sick last yr. Chiron and Aventis Pasteur, the two producers of vaccine photographs, will doubtless produce more doses subsequent 12 months to avoid shortages, he mentioned, threatening to depart MedImmune with an overpriced product with not a lot of a market.

Add comment

INDEXING JOURNAL: